4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001649094-24-000062
SVP, GEN COUNSEL & CORP SEC sold 1,667 shares at an average $112.11 ($186,880)
- SVP, GEN COUNSEL & CORP SEC gave up 2,203 shares (to pay taxes)
- SVP, GEN COUNSEL & CORP SEC acquired 1,667 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-09-03 | Option exercise 10b5-1 | +1,667 | $21.41 | $35,690 | 32,493 | D: show line 1 in the form |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-09-03 | Sale 10b5-1 | −4 | $107.67 | $431 | 32,489 | D: show line 2 in the form |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-09-03 | Sale 10b5-1 | −523 | $110.45 | $57,765 | 31,966 | D: show line 3 in the form |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-09-03 | Sale 10b5-1 | −715 | $111.57 | $79,770 | 31,251 | D: show line 4 in the form |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-09-03 | Sale 10b5-1 | −122 | $112.66 | $13,745 | 31,129 | D: show line 5 in the form |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-09-03 | Sale 10b5-1 | −79 | $114.96 | $9,082 | 31,050 | D: show line 6 in the form |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-09-03 | Sale 10b5-1 | −144 | $116.01 | $16,705 | 30,906 | D: show line 7 in the form |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-09-03 | Sale 10b5-1 | −80 | $117.28 | $9,382 | 30,826 | D: show line 8 in the form |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-09-03 | Shares withheld for taxes 10b5-1 | −2,203 | $110.15 | $242,660 | 28,623 | D: show line 9 in the form |
| Open-market sales · 1,667 sh · avg $112.11 · $186,880 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-09-03 | Option exercise · Stock Option (right to buy) 10b5-1 | −1,667 | 179,997 | D: show line 10 in the form |
Loading xslF345X05/wk-form4_1725570829.xml…